A clinical trial to study the effect of two drugs, dexmedetomidine and magnesium sulphate during awake fibreoptic orotracheal intubation in patients undergoing cervical spine surgery.

A comparative evaluation of dexmedetomidine and magnesium sulphate during awake fibreoptic orotracheal intubationin patients scheduled for cervical spine surgeries : a prospective study.

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/12/048084

Enrollment

Registered

2022-12-13

Start date

Unknown

Completion date

Unknown

Last updated

2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G958- Other specified diseases of spinalcord

Interventions

Intervention1: Dexmedetomidine: Intravenous infusion of Dexmedetomidine (1Î¼g/kg) in 100 ml Normal saline 10 minutes before induction. Control Intervention1: Magnesium Sulphate: Intravenous infusion o

Eligibility

Inclusion criteria

Inclusion criteria: 1. Consent to participate in the study. 2. ASA grade I & II. 3. Patients undergoing cervical spine surgery under general anaesthesia.

Exclusion criteria

Exclusion criteria: 1. Patient with Cardiovascular, Hepatic, Renal, or Neuromuscular disorder. 2. Patients with ASA Grade III and IV. 3. Coagulopathy or bleeding diathesis. 4. Patients with other associated facial, skull base and/or mandibular fractures.

Design outcomes

Primary

Measure	Time frame
To assess the level of sedation and cough score and intubation score during AFOITimepoint: Intraoperatively	—

Secondary

Measure	Time frame
To compare the hemodynamic parameters between dexmedetomidine and magnesium sulphateTimepoint: Intraoperatively	—

Countries

India

Contacts

Public ContactDr Ekta Bansal

Gajra Raja Medical College, Gwalior

drseema26@gmail.com7566439701

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026